No significant association was found between EZH2 expression and other clinicopathological parameters, including ethnicity, pathological T stage, FIGO stage, depth of myometrial invasion, or lymph node metastasis (p > 0.05) (Table 2). Here, EZH2 is linked to metastatic malignant neoplasm in the lymph nodes.